Market Chatter: Tesla CEO Elon Musk Amends Lawsuit Against OpenAI to Direct Potential Damages to Charity

MT Newswires Live04-08

Tesla (TSLA) Chief Executive Officer Elon Musk Tuesday, amended his lawsuit against Microsoft (MSFT)-backed OpenAI to request that any damages awarded be directed to the organization's charitable arm rather than to himself, as the high-profile case heads toward trial later this month in Oakland, California, The Wall Street Journal reported.

Musk is seeking more than $150 billion in damages from OpenAI and its partner Microsoft, alleging the company departed from its original nonprofit mission and misled him as an early donor while shifting toward a for-profit structure.

The amended complaint, per WSJ, also asks a court to remove OpenAI CEO Sam Altman from the nonprofit board and require Altman and OpenAI President Greg Brockman to transfer any equity or financial benefits tied to the restructuring to the charity arm.

Musk's attorney Marc Toberoff told the publication that the amendment clarifies that Musk "is not seeking a single dollar for himself."

OpenAI, in an X post, rejected the claims, calling the lawsuit "a harassment campaign."

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment